Objective:

To investigate the increasing prevalence and impact of nitazenes, a class of highly potent synthetic opioids, in the United States.

Approach:

Key Findings:

• Nitazene-related overdose deaths in the U.S. rose from 27 in 2020 to 409 in 2024, with 747 confirmed deaths in 2023 and 2024.
• Nitazenes can be up to 40 times more potent than fentanyl and 500 times stronger than heroin.
• The U.S. has reported 26 different kinds of nitazenes since 2019, with over 1,100 confirmed fatalities.
• Ohio has the highest number of nitazene-related overdose deaths and laboratory reports in the U.S.
• Nitazenes are often mixed with other drugs, increasing the risk of fatal overdoses.

Interpretation:

The rise of nitazenes poses a significant public health threat, particularly as they are frequently mixed with other substances, complicating overdose risks.

Limitations:

• Deaths from nitazenes may be underreported due to limited testing capabilities in forensic labs.
• Not all laboratories report nitazene data to national databases, leading to potential underestimation of the issue.

Conclusion:

The investigation highlights the need for increased awareness and testing to address the growing threat of nitazenes.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.